ATHA Energy Announces Latitude Uranium Obtains Shareholder Approval for Transaction
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is […]
Latitude Uranium Announces Voting Results from Special Meeting
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — Latitude Uranium Inc. (“Latitude Uranium”, “LUR” or the “Company”) (CSE: LUR, OTCQB: LURAF, […]
Lancaster Resources Acquires High-Impact Uranium Claims in Athabasca Basin
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTCQB:LANRF) (FRA:6UF) (“Lancaster”), Lancaster Resources, a North […]
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) […]
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) […]
EnviroGold Global Announces Positive Initial Test Results with a Second Major Global Metal Production Company
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” […]
Refined Metals Corp. and Eagle Plains Resources Enter into an Option Agreement for the Dufferin Project in the Athabasca Basin
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Refined Metals Corp. (CSE: RMC; OTC: RFMCF; FRA: CWA0) (the “Company”) […]
ATHA Energy Announces Appointment of Ryan Gaffney as Senior Vice President, Business Development
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or […]
Draganfly Announces Closing of US$3.6 Million Underwritten Public Offering
Saskatoon, SK., Feb. 26, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER […]
